PL379196A1 - Nowe zmodyfikowane cząsteczki koryny posiadające substytut sekwencji aktywacji i ich zastosowanie - Google Patents

Nowe zmodyfikowane cząsteczki koryny posiadające substytut sekwencji aktywacji i ich zastosowanie

Info

Publication number
PL379196A1
PL379196A1 PL379196A PL37919604A PL379196A1 PL 379196 A1 PL379196 A1 PL 379196A1 PL 379196 A PL379196 A PL 379196A PL 37919604 A PL37919604 A PL 37919604A PL 379196 A1 PL379196 A1 PL 379196A1
Authority
PL
Poland
Prior art keywords
activation sequences
novel modified
modified corin
substitute activation
corin molecules
Prior art date
Application number
PL379196A
Other languages
English (en)
Inventor
Qingyu Wu
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of PL379196A1 publication Critical patent/PL379196A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL379196A 2003-06-11 2004-06-09 Nowe zmodyfikowane cząsteczki koryny posiadające substytut sekwencji aktywacji i ich zastosowanie PL379196A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47768303P 2003-06-11 2003-06-11

Publications (1)

Publication Number Publication Date
PL379196A1 true PL379196A1 (pl) 2006-07-24

Family

ID=33551745

Family Applications (1)

Application Number Title Priority Date Filing Date
PL379196A PL379196A1 (pl) 2003-06-11 2004-06-09 Nowe zmodyfikowane cząsteczki koryny posiadające substytut sekwencji aktywacji i ich zastosowanie

Country Status (15)

Country Link
US (1) US7176013B2 (pl)
EP (1) EP1636356A1 (pl)
JP (1) JP2007502132A (pl)
KR (1) KR20060022683A (pl)
CN (2) CN1836037A (pl)
AU (1) AU2004248192A1 (pl)
BR (1) BRPI0411353A (pl)
CA (1) CA2527361A1 (pl)
IL (1) IL172095A0 (pl)
MX (1) MXPA05013321A (pl)
NO (1) NO20060144L (pl)
PL (1) PL379196A1 (pl)
RU (1) RU2006100035A (pl)
WO (1) WO2004111225A1 (pl)
ZA (1) ZA200600224B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050026255A1 (en) * 2002-06-25 2005-02-03 Morser John Michael Corin, a serine protease
TW200723151A (en) * 2005-12-07 2007-06-16 Era Digital Media Co Business website method
WO2009120760A1 (en) * 2008-03-28 2009-10-01 The Cleveland Clinic Foundation Corin for treating obesity and diabetes
US20110306069A1 (en) 2009-02-19 2011-12-15 Qingyu Wu Corin As A Marker For Heart Failure
US10314894B2 (en) * 2014-02-12 2019-06-11 The Cleveland Clinic Foundation Treatment of cardio-renal disease using PCSK6
DK3422845T3 (da) 2016-02-29 2021-08-30 Regeneron Pharma Gnavere med et humaniseret tmprss-gen
CN105734070A (zh) * 2016-04-11 2016-07-06 苏州大学 Corin基因变异体及其用途
CN108066286B (zh) * 2016-11-10 2021-06-29 复旦大学 炔丙基半胱氨酸纳米粒长循环脂质体及其制备方法和用途
CN118530307B (zh) * 2024-06-14 2025-09-09 中国人民解放军军事科学院军事医学研究院 一种阻断pts途径的多肽及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK275788A (da) * 1987-05-22 1989-02-03 Zymogenetics Inc Fibrinolytiske proteiner
US5869637A (en) 1996-07-22 1999-02-09 Incyte Pharmaceuticals, Inc. Human Kallikrein
WO1998024886A1 (en) * 1996-12-04 1998-06-11 Brigham And Women's Hospital, Inc. Mast cell protease that cleaves fibrinogen
WO1998036054A1 (en) 1997-02-13 1998-08-20 Amrad Operations Pty. Ltd. Novel molecules
AU9260598A (en) * 1997-08-22 1999-03-16 Boehringer Mannheim Gmbh Zymogenic protease precursors that can be autocatalytically activated and their use
EP0927764B1 (de) 1997-12-03 2004-05-26 Boehringer Mannheim Gmbh Chimäre Serinproteasen
JP4488140B2 (ja) * 1998-06-05 2010-06-23 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト セリンプロテアーゼであるコリン
US6420157B1 (en) * 1999-04-30 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Zymogen activation system
JP2003521920A (ja) * 2000-02-03 2003-07-22 コルバス・インターナショナル・インコーポレイテッド 膜貫通セリンプロテアーゼをコードしている核酸分子、コードされたタンパク質、およびそれらに基づく方法
US6906176B2 (en) * 2000-06-19 2005-06-14 Dyax Corp. Enterokinase cleavage sequences
CN1231262C (zh) * 2000-09-04 2005-12-14 金晓骏 载脂蛋白b－100表位的模拟肽、其多联体和修饰肽,以及含有这些肽的疫苗组合物
FR2831170B1 (fr) * 2001-10-19 2004-03-19 Inst Nat Sante Rech Med Proteines c modifiees activables directement par la thrombine
US20040132156A1 (en) * 2002-10-04 2004-07-08 Schering Aktiengesellschaft Modified hepsin molecules having a substitute activation sequence and uses thereof

Also Published As

Publication number Publication date
BRPI0411353A (pt) 2006-07-11
MXPA05013321A (es) 2006-03-09
ZA200600224B (en) 2007-04-25
CA2527361A1 (en) 2004-12-23
IL172095A0 (en) 2009-02-11
CN101109011A (zh) 2008-01-23
KR20060022683A (ko) 2006-03-10
WO2004111225A1 (en) 2004-12-23
US7176013B2 (en) 2007-02-13
JP2007502132A (ja) 2007-02-08
NO20060144L (no) 2006-01-10
CN1836037A (zh) 2006-09-20
RU2006100035A (ru) 2006-08-27
EP1636356A1 (en) 2006-03-22
WO2004111225A8 (en) 2006-04-06
US20050003416A1 (en) 2005-01-06
AU2004248192A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
SG128680A1 (en) Binding molecules against sars-coronavirus and uses thereof
IL229509A0 (en) Preparations containing chemically modified small molecules and processes using them
AU2003230410A1 (en) Rinse-added fabric treatment composition and methods and uses thereof
IL174479A0 (en) Hemiasterlin derivatives and uses thereof
AU2003243562A8 (en) Polymeric label molecules
AU2003279754A8 (en) Modified hepsin molecules having a substitute activation sequence and uses thereof
IL172095A0 (en) Novel modified corin molecules having substitute activation sequences and uses thereof
GB0309064D0 (en) Modified peptides and their uses
AU2002953223A0 (en) Novel therapeutic molecules and uses thereof
HK1085509A (en) Novel modified corin molecules having substitute activation sequences and uses thereof
GB2392746B (en) Comparison of molecules using field points
EP1487547A4 (en) MEDIUM FOR PHYSICAL INTERACTION AND ITS RELATED USES
AU2003219732A8 (en) Oligomeric molecules and uses thereof
AU2003239717A8 (en) Card-4 molecules and uses thereof
EP1699809A4 (en) PEPTIDE FROM AMNIOTIC LIQUID AND USES THEREOF
AUPS161602A0 (en) Novel molecules and uses therefor
GB0308241D0 (en) Screening methods and sequences relating thereto
GB0306185D0 (en) Molecules
GB0213651D0 (en) Nucleotide sequences and uses thereof
GB0213658D0 (en) Nucleotide sequences and uses thereof
WO2005063292A8 (en) Heh4 molecules and uses thereof
GB0211232D0 (en) Molecules
GB0209619D0 (en) Molecules
AU2003263751A8 (en) Novel proteins and their uses
GB0318162D0 (en) Polishes and their uses

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)